Active Mental Health Psychology & Behaviour

Uncovering Sex-Specific Biological Mechanisms of Depression: Insights from Large-Scale Data Analysis

In plain English

AI plain-English summary

Women are twice as likely as men to experience depression, and this project will analyse DNA and molecular data from millions of people to uncover why. The problem is that current depression treatments often rely on trial and error, partly because researchers do not fully understand the biological differences between depression in women and men. Previous work using data from nearly 300,000 people found that different genes are involved in female and male depression. This project will scale that analysis to millions of people, and also examine the often-overlooked sex chromosomes (X and Y) for genes that may be switched on or off during depression. The team will also test whether skewed X-chromosome inactivation—where one parental copy is disproportionately silenced—occurs in women with depression, as it does in other mental health conditions. If successful, the research could help doctors predict which antidepressant will work for a given patient based on their DNA, reducing the need for patients to try multiple drugs before finding one that helps. The team will test this directly using UK Biobank data linked to prescription records, checking whether people predicted to not respond to a drug actually switch treatments. The project will also produce molecular profiles of depression separately for women and men, and determine whether changes in blood molecules are a cause or consequence of the disorder.

View original technical description
Depression causes feelings of low mood and a loss of interest in things that used to be enjoyable. One in six people suffer from depression during their lifetime. However, women are twice as likely to have depression compared to men. There are likely to be a number of reasons for this difference, although we don't yet fully understand them. Biology is likely to play an important role in this difference between the sexes and my research will explore this in more detail. My previous work has shown that different genes are involved in female depression compared to depression in men. This previous research used data from nearly 300,000 people. The new work will examine millions of people and will greatly improve on what we can detect. The results from this first project will also be used to identify the sections of DNA that might be good targets for antidepressant drugs. If we can discover which drugs are likely to work based on someone's DNA, we can also then figure out which drugs might not work. We will then test this using the UK Biobank. The UK Biobank has DNA information and is linked up to past prescription records. So, we can check whether the people we think won't respond to a drug based on their DNA actually end up switching treatments. It is hoped this work will help doctors decide on the best medication for each patient with depression. Some DNA is inherited via the sex chromosomes (known as the X and Y chromosomes). However, the sex chromosomes are often overlooked in depression research even though they might contain useful information. Genes are turned on and off at different points during our lives and so this may also happen when someone becomes depressed. Using the largest data available we will see if we can find evidence of genes on the sex chromosomes being turned on or off due to depression. Females get two X chromosomes, one inherited from their mother and one from their father. In every cell in the female body, one of these X chromosomes is inactivated. This is normally a random process. So, half of cells have the X chromosome from their mother inactivated, and the other half of cells have the X chromosome inherited from their father inactivated. However, in some women there are more cells that have either the X chromosome from their mother or father inactivated, which is known as skewness. This skewness has been observed in other mental health conditions and we will look at whether it occurs in depression. There are molecules that circulate in our blood that might put us at greater or lower risk of depression. We will look at new molecular data from the UK Biobank to identify those molecules that differ for people with depression. We will do this separately for women and men using state-of-the-art methods. This will provide us with molecular profiles for depression. We will then test whether any molecules differ between men and women in their link with depression. The final project will look at whether changes in particular molecules lead to depression, or these changes are because of having depression. Each of these projects will provide us with further clues about the biology of depression. The hope is that this information will identify the best treatment for those with the disorder.

View the original record at the funder ↗

Researchers

David Mark Howard (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

A multi-omic approach to investigating biological mechanisms related to the aetiology and treatment of major depressive disorder.
Using genetics to understand the complex relationships between obesity and depression in diverse global settings
Examining the causes and consequences of sub-types of depression across the life course
Identifying and characterising a cellular blood biomarker in treatment-resistant depression
Using molecular and clinical data to predict outcomes to treatments for depression

Original classification

Fellowship

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.